Memorial Symptom Assessment Scale

Known as: MSAS, Memorial Symptom Assessment Scale - MSAS 
A patient-rated instrument developed to provide multidimensional information about a diverse group of common symptoms. This 32-question, self-rated… (More)
National Institutes of Health

Related topics

Related topics

36 relations
Cough FrequencyFrequency of Pain QuestionHow Much Distress DiarrheaHow Much Distress Dry Mouth
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Understanding breathlessness: cross-sectional comparison of symptom burden and palliative care needs in chronic obstructive pulmonary disease and cancer.
BACKGROUND Little is known about symptom burden and palliative care needs of breathless patients with advanced cancer and chronic… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening adverse drug reactions characterized by… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Symptom distress and quality of life in patients with advanced congestive heart failure.
Little is known about the burden of illness associated with advanced congestive heart failure (CHF). Understanding the needs of… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 4
Is this relevant?
2004
2004
Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS).
BACKGROUND Rapid and efficient symptom assessment is an important aspect of palliative care. The objective was to determine… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer
Although many patients with ovarian cancer achieve favorable responses to primary chemotherapy, the majority of women will… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale.
The objectives of this study were twofold: (1) to explore and compare the symptom experience of seriously ill hospitalized cancer… (More)
  • table 1
  • table 2
  • table 4
  • table 5
  • table 6
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12.
Few studies have attempted to describe the experience of symptoms in young children with cancer. This is due, in part, to the… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The memorial symptom assessment scale short form (MSAS-SF).
BACKGROUND The Memorial Symptom Assessment Scale Short Form (MSAS-SF), an abbreviated version of the Memorial Symptom Assessment… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The measurement of symptoms in children with cancer.
The purpose of this study was to determine symptom prevalence, characteristics, and distress in children with cancer. The… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.
The Memorial Symptom Assessment Scale (MSAS) is a new patient-rated instrument that was developed to provide multidimensional… (More)
  • table 1
  • table 2
  • figure 1
  • figure 1
  • table 3
Is this relevant?